Christopher White has joined the company as Senior Vice President and Head of Business and Corporate Development (news posted on July 12 2019).
Patricia Kitchen has joined the company as Chief Operations Officer (news posted on July 9 2019).
Seung Suh Hong has joined the company as Director (news posted on April 24 2019).
Create an alert
to follow the executive moves at Ocular Therapeutix.
Zambon has acquired Breath Therapeutics (posted on Jul 29, 2019).
Cognizant has announced the acquisition of Zenith Technologies (posted on Jun 18, 2019).
Dassault Systemes has announced the acquisition of Medidata Solutions (posted on Jun 14, 2019).
Ocular Therapeutix™ Reports Second Quarter 2019 Financial Results and Business Update | Ocular Therapeutix, Inc.
Ocular Therapeutix™ To Report Second Quarter 2019 Financial Results | Ocular Therapeutix, Inc.
Ocular Therapeutix™ Announces Early Assignment of Permanent and Specific J-Code (J1096) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4mg by the Centers for Medicare and Medicaid Services | Ocular Therapeutix, Inc.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Ocular Therapeutix, Inc.
Ocular Therapeutix™ Announces Christopher White as Senior Vice President, Head of Business and Corporate Development | Ocular Therapeutix, Inc.
Ocular Therapeutix has 1,288 competitors including Aldeyra Therapeutics (United States (USA)), Janssen Research & Development (United States (USA)) and Charles River Laboratories International (United States (USA)).
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.